IMHO I think that the Magellan group could possibly still have a few more shares to sell. So we just need to be patient until they have finished this process. D.Y.O.R Klaas
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
